TY - JOUR
T1 - Differences in C‐myc and pvt‐1 amplification in sewa sarcoma sublines selected for adherent or non‐adherent growth
AU - Minarovits, Janos
AU - Steinitz, Michael
AU - Boldog, Ferenc
AU - Imreh, Stephan
AU - Wirschubsky, Zvi
AU - Ingvarsson, Sigurdur
AU - Hedenskog, Mona
AU - Minarovits‐Kormuta, Susanna
AU - Klein, George
PY - 1990/3/15
Y1 - 1990/3/15
N2 - Conversion of solid sarcomas and carcinomas into ascites tumors depends on the in vivo selection of phenotypically altered tumor cell variants that can grow in the dissociated form. Once selected, they retain this property even after prolonged s.c. growth as solid tumors. From an s.c.‐passaged subline of an ascites‐converted murine sarcoma (SEWA‐AS12), we were able to separate cells adapted to the ascites form of growth from cells that can only grow in the solid form on the basis of their differential adherence to plastic. Both c‐myc and pvt‐1 were amplified approximately 63‐ to 77‐fold in the nonadherent subline (SEWA‐AS12‐NA), but only 5‐ to 8‐fold in the adherent subine (SEWA‐AS12‐ADH). This suggests that c‐myc and/or pvt‐1 amplification may provide a selective advantage to cells that can grow in the dissociated form.
AB - Conversion of solid sarcomas and carcinomas into ascites tumors depends on the in vivo selection of phenotypically altered tumor cell variants that can grow in the dissociated form. Once selected, they retain this property even after prolonged s.c. growth as solid tumors. From an s.c.‐passaged subline of an ascites‐converted murine sarcoma (SEWA‐AS12), we were able to separate cells adapted to the ascites form of growth from cells that can only grow in the solid form on the basis of their differential adherence to plastic. Both c‐myc and pvt‐1 were amplified approximately 63‐ to 77‐fold in the nonadherent subline (SEWA‐AS12‐NA), but only 5‐ to 8‐fold in the adherent subine (SEWA‐AS12‐ADH). This suggests that c‐myc and/or pvt‐1 amplification may provide a selective advantage to cells that can grow in the dissociated form.
UR - http://www.scopus.com/inward/record.url?scp=0025234945&partnerID=8YFLogxK
U2 - 10.1002/ijc.2910450324
DO - 10.1002/ijc.2910450324
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 2307540
AN - SCOPUS:0025234945
SN - 0020-7136
VL - 45
SP - 514
EP - 520
JO - International Journal of Cancer
JF - International Journal of Cancer
IS - 3
ER -